We are live on ! Find out more
NAUT icon

Nautilus Biotechnolgy

44 hedge funds and large institutions have $165M invested in Nautilus Biotechnolgy in 2021 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 5 increasing their positions, 12 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

15% more capital invested

Capital invested by funds: $143M → $165M (+$21.9M)

2% more funds holding

Funds holding: 4344 (+1)

6% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 16

1% less call options, than puts

Call options by funds: $393K | Put options by funds: $395K

7.88% less ownership

Funds ownership: 85.54%77.66% (-7.9%)

58% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 12

Holders
44
Holders Change
+1
Holders Change %
+2.33%
% of All Funds
0.77%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
17
Increased
5
Reduced
12
Closed
16
Calls
$393K
Puts
$395K
Net Calls
-$2K
Net Calls Change
-$2K
Name Holding Trade Value Shares
Change
Change in
Stake
WAM
51
Weiss Asset Management
Massachusetts
-$1.02M -94,100 Closed
MCM
52
Moore Capital Management
New York
-$543K -50,000 Closed
PC
53
Periscope Capital
Ontario, Canada
-$543K -50,000 Closed
CC
54
Centiva Capital
New York
-$401K -37,000 Closed
Mirae Asset Global Investments
55
Mirae Asset Global Investments
South Korea
-$174K -16,068 Closed
OWP
56
Old Well Partners
North Carolina
-$141K -12,954 Closed
ECM
57
ExodusPoint Capital Management
New York
-$108K -10,000 Closed
KC
58
KCL Capital
New York
-$109K -10,000 Closed
TRCT
59
Tower Research Capital (TRC)
New York
+$208 +15 New